AVXL
Price
$5.69
Change
-$1.21 (-17.54%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
488.74M
38 days until earnings call
Intraday BUY SELL Signals
SLGL
Price
$35.58
Change
+$4.08 (+12.95%)
Updated
Nov 13 closing price
Capitalization
99.1M
117 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVXL vs SLGL

Header iconAVXL vs SLGL Comparison
Open Charts AVXL vs SLGLBanner chart's image
Anavex Life Sciences
Price$5.69
Change-$1.21 (-17.54%)
Volume$60.55K
Capitalization488.74M
Sol-Gel Technologies
Price$35.58
Change+$4.08 (+12.95%)
Volume$114.96K
Capitalization99.1M
AVXL vs SLGL Comparison Chart in %
AVXL
Daily Signal:
Gain/Loss:
SLGL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVXL vs. SLGL commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and SLGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AVXL: $6.90 vs. SLGL: $31.50)
Brand notoriety: AVXL and SLGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 126% vs. SLGL: 302%
Market capitalization -- AVXL: $488.74M vs. SLGL: $99.1M
AVXL [@Biotechnology] is valued at $488.74M. SLGL’s [@Biotechnology] market capitalization is $99.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileSLGL’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • SLGL’s FA Score: 0 green, 5 red.
According to our system of comparison, SLGL is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 4 TA indicator(s) are bullish while SLGL’s TA Score has 4 bullish TA indicator(s).

  • AVXL’s TA Score: 4 bullish, 6 bearish.
  • SLGL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLGL is a better buy in the short-term than AVXL.

Price Growth

AVXL (@Biotechnology) experienced а -5.61% price change this week, while SLGL (@Biotechnology) price change was -3.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

AVXL is expected to report earnings on Dec 22, 2025.

SLGL is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($489M) has a higher market cap than SLGL($99.1M). SLGL YTD gains are higher at: 238.673 vs. AVXL (-35.754). SLGL has higher annual earnings (EBITDA): -4.59M vs. AVXL (-45.88M). AVXL has more cash in the bank: 101M vs. SLGL (24.3M). AVXL has less debt than SLGL: AVXL (88.2K) vs SLGL (1.18M). SLGL has higher revenues than AVXL: SLGL (23.9M) vs AVXL (0).
AVXLSLGLAVXL / SLGL
Capitalization489M99.1M493%
EBITDA-45.88M-4.59M1,000%
Gain YTD-35.754238.673-15%
P/E RatioN/AN/A-
Revenue023.9M-
Total Cash101M24.3M416%
Total Debt88.2K1.18M7%
FUNDAMENTALS RATINGS
AVXL vs SLGL: Fundamental Ratings
AVXL
SLGL
OUTLOOK RATING
1..100
5356
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
9793
PRICE GROWTH RATING
1..100
8934
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVXL's Valuation (41) in the Biotechnology industry is in the same range as SLGL (65) in the Pharmaceuticals Major industry. This means that AVXL’s stock grew similarly to SLGL’s over the last 12 months.

AVXL's Profit vs Risk Rating (91) in the Biotechnology industry is in the same range as SLGL (100) in the Pharmaceuticals Major industry. This means that AVXL’s stock grew similarly to SLGL’s over the last 12 months.

SLGL's SMR Rating (93) in the Pharmaceuticals Major industry is in the same range as AVXL (97) in the Biotechnology industry. This means that SLGL’s stock grew similarly to AVXL’s over the last 12 months.

SLGL's Price Growth Rating (34) in the Pharmaceuticals Major industry is somewhat better than the same rating for AVXL (89) in the Biotechnology industry. This means that SLGL’s stock grew somewhat faster than AVXL’s over the last 12 months.

SLGL's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as AVXL (100) in the Biotechnology industry. This means that SLGL’s stock grew similarly to AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLSLGL
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signal:
Gain/Loss:
SLGL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LYRNX14.850.13
+0.88%
Lyrical International Value Equity Inv
BMCRX29.730.04
+0.13%
BlackRock Advantage Large Cap Gr R
RYSPX103.480.06
+0.06%
Rydex S&P 500 H
JLVIX78.890.05
+0.06%
JHancock Fundamental Large Cap Core I
FEATX61.25N/A
N/A
Fidelity Advisor Emerging Asia M

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+0.73%
PLRX - AVXL
48%
Loosely correlated
+7.78%
TENX - AVXL
47%
Loosely correlated
-0.71%
AXON - AVXL
45%
Loosely correlated
-0.47%
VCYT - AVXL
41%
Loosely correlated
-0.84%
ARRY - AVXL
41%
Loosely correlated
-8.69%
More

SLGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLGL has been loosely correlated with TRAW. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SLGL jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLGL
1D Price
Change %
SLGL100%
-1.20%
TRAW - SLGL
46%
Loosely correlated
+13.23%
RAPT - SLGL
40%
Loosely correlated
-0.27%
CMND - SLGL
37%
Loosely correlated
-32.32%
NEUP - SLGL
33%
Poorly correlated
+0.20%
AVXL - SLGL
31%
Poorly correlated
+0.73%
More